Clinical Study
Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy
Table 1
The ages and initial dose of the patients treated with antithyroid drug who developed and did not develop adverse events.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
There were no significant differences between maternal age and the starting dose of ATD (MMI and PTU) in the group that developed adverse events and the group that did not develop adverse events. There was no significant difference in frequency of adverse events between MMI and PTU. |